UK Supreme Court’s Actavis ruling finds balance for pharma and generics: lawyers

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

UK Supreme Court’s Actavis ruling finds balance for pharma and generics: lawyers

Ed Conlon
March 28 2019
UK Supreme Court thumb

The UK Supreme Court’s ruling in Actavis v Icos is likely to satisfy pharmaceutical and generics companies, according to lawyers involved in the case

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

United KingdomNewsPatentsEurope
conlon-ed-300px.png
Ed Conlon
Head of Editorial Content Managing IP
Contact
Ed oversees the coverage by Managing IP and its sister publications International Tax Review and International Financial Law Review.
more from across site and SHARED ros bottom lb

More from across our site

Patents
clark-michelle.jpg
Alston & Bird hire anticipates IP disputes focus
Michelle Clark, who has a generalist litigation background, plans to focus on IP disputes at Alston & Bird
Rani Mehta, April 15 2025
Gift this article